Louis, Renaud ; Université de Liège - ULiège > Département des sciences cliniques > Pneumologie - Allergologie
Roche, N.; Respiratory and Intensive Care Medicine, Cochin Hospital, Hôpitaux Universitaires Paris Centre (APHP) and University Paris Descartes (EA2511), Paris, France
Chung KF. Personalised medicine in asthma: time for action. Eur Respir Rev 2017; 26: 170064.
Guilleminault L, Ouksel H, Belleguic C, et al. Personalised medicine in asthma: from curative to preventive medicine. Eur Respir Rev 2017; 26: 160010.
Flores M, Glusman G, Brogaard K, et al. P4 medicine: how systems medicine will transform the healthcare sector and society. Per Med 2013; 10: 565-576.
Bousquet J, Barbara C, Bateman E, et al. AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation. Eur Respir J 2016; 47: 1028-1033.
Sznajder JI, Ciechanover A. Personalized medicine: the road ahead. Am J Respir Crit Care Med 2012; 186: 945-947.
Schleidgen S, Klingler C, Bertram T, et al. What is personalized medicine: sharpening a vague term based on a systematic literature review. BMC Med Ethics 2013; 14: 55.
Caillaud D, Chanez P, Escamilla R, et al. Asthma-COPD overlap syndrome (ACOS) vs “pure” COPD: a distinct phenotype? Allergy 2017; 72: 137-145.
Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
Burgel PR, Paillasseur JL, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int 2014; 2014: 420134.
Casale TB. Biologics and biomarkers for asthma, urticaria, and nasal polyposis. J Allergy Clin Immunol 2017; 139: 1411-1421.
Woodruff PG, Agusti A, Roche N, et al. Current concepts in targeting chronic obstructive pulmonary disease pharmacotherapy: making progress towards personalised management. Lancet 2015; 385: 1789-1798.
Agustí A, Antó JM, Auffray C, et al. Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014. Am J Respir Crit Care Med 2015; 191: 391-401.
Diez D, Agustí A, Wheelock CE. Network analysis in the investigation of chronic respiratory diseases. From basics to application. Am J Respir Crit Care Med 2014; 190: 981-988.
Alyass A, Turcotte M, Meyre D. From big data analysis to personalized medicine for all: challenges and opportunities. BMC Med Genomics 2015; 8: 33.
Hood L. Systems biology: integrating technology, biology, and computation. Mech Ageing Dev 2003; 124: 9-16.
Hellmann DB, Ziegelstein RC. Personomics: a new series in the Green Journal. Am J Med 2017; 130: 622.
FitzGerald JM, Poureslami I. The need for humanomics in the era of genomics and the challenge of chronic disease management. Chest 2014; 146: 10-12.
Louis RE, Joos GF. Eosinophilia and chronic airway diseases. BRN Rev 2016; 2: 143-158.
Kuo C-HS, Pavlidis S, Loza M, et al. T-helper cell type 2 (Th2) and non-Th2 molecular phenotypes of asthma using sputum transcriptomics in U-BIOPRED. Eur Respir J 2017; 49: 1602135.
Darveaux J, Busse WW. Biologics in asthma-the next step toward personalized treatment. J Allergy Clin Immunol Pract 2015; 3: 152-160.
Gibson PG, Yang IA, Upham JW, et al. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial. Lancet 2017; 390: 659-668.
Quaedvlieg V, Henket M, Sele J, et al. Cytokine production from sputum cells in eosinophilic versus non-eosinophilic asthmatics. Clin Exp Immunol 2006; 143: 161-166.
Louis R, Schleich F, Barnes PJ. Corticosteroids: still at the frontline in asthma treatment? Clin Chest Med 2012; 33: 531-541.
Korevaar DA, Westerhof GA, Wang J, et al. Diagnostic accuracy of minimally invasive markers for detection of airway eosinophilia in asthma: a systematic review and meta-analysis. Lancet Respir Med 2015; 3: 290-300.
Demarche SF, Schleich FN, Paulus VA, et al. Is it possible to claim or refute sputum eosinophils ⩾3% in asthmatics with sufficient accuracy using biomarkers? Respir Res 2017; 18: 133.
Mascaux C, Tomasini P, Greillier L, et al. Personalised medicine for nonsmall cell lung cancer. Eur Respir Rev 2017; 26: 170066.
Bonsignore MR, Suarez Giron MC, Marrone O, et al. Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment. Eur Respir Rev 2017; 26: 170069.
